Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Tysabri (Natalizumab) Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tysabri Covered by Aetna CVS Health in Florida Fastest path to approval: Aetna requires prior authorization for Tysabri (natalizumab) with mandatory TOUCH program enrollment for both patient and prescriber. Document failed first-line DMTs, submit complete clinical justification, and ensure all REMS requirements are met. If denied, Florida

Get Mavenclad (Cladribine) Approved by Aetna CVS Health in New York: Complete Coverage Guide

Answer Box: Fast Track to Mavenclad Coverage Mavenclad requires prior authorization from Aetna CVS Health in New York. Your fastest path: (1) Confirm relapsing MS diagnosis and document at least two failed disease-modifying therapies, (2) Have your neurologist submit a medical necessity letter with lab results showing lymphocyte count ≥800

Renewing Taltz (Ixekizumab) Approval with Aetna CVS Health in California: Complete Renewal Guide 2025

Answer Box: Renewing Your Taltz (Ixekizumab) Authorization Start renewal 2-4 weeks before expiration. Submit updated clinical notes showing continued benefit, current diagnosis (ICD code), and safety monitoring via Aetna's precertification fax (1-877-269-9916). If denied, file internal appeal within 180 days, then California Independent Medical Review (IMR) through DMHC.

How to Get Kanuma (sebelipase alfa) Covered by Aetna (CVS Health) in Illinois: Complete Guide with Forms, Timelines, and Appeal Scripts

Answer Box: Getting Kanuma Covered by Aetna in Illinois Yes, Aetna (CVS Health) covers Kanuma (sebelipase alfa) in Illinois, but requires prior authorization. The fastest path: (1) Submit PA request via Availity provider portal with LAL enzyme deficiency test results and LIPA gene mutation confirmation, (2) Include documentation of hepatic/

Oxbryta (Voxelotor) Denied by Aetna CVS Health in New Jersey: Understanding the 2024 FDA Withdrawal and Your Appeal Options

Answer Box: Oxbryta Coverage Status Oxbryta (voxelotor) is no longer FDA-approved as of September 2024 due to increased vaso-occlusive crises and deaths in sickle cell disease patients. Aetna CVS Health now categorically denies all Oxbryta claims based on this regulatory withdrawal. Your immediate steps: 1) Contact your hematologist to plan

How to Get Eylea and Lucentis Covered by Aetna CVS Health in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Started To get Eylea or Lucentis covered by Aetna CVS Health in Michigan: First, ensure your ophthalmologist tries bevacizumab (Avastin) unless contraindicated—Aetna requires step therapy. Submit prior authorization with OCT imaging showing retinal thickness ≥300 microns, visual acuity ≤20/40, and documented medical necessity. If denied,

How to Get Ocrevus (ocrelizumab) Covered by Aetna CVS Health in New Jersey: Appeals, Alternatives & Approval Strategies

Answer Box: Aetna CVS Health covers Ocrevus (ocrelizumab) for multiple sclerosis in New Jersey but requires prior authorization and often step therapy with preferred DMTs first. If denied, you have 180 days to appeal through two internal levels, then New Jersey's IHCAP external review (success rate ~50% for

How to Get Retevmo (Selpercatinib) Covered by Aetna in Washington: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Retevmo Covered by Aetna in Washington Aetna requires prior authorization for Retevmo (selpercatinib), with documentation of RET fusion testing and step therapy compliance. Most approvals take 72 hours with complete documentation. If denied, you have 60 days to appeal internally, then can request external review through Washington&

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Photrexa Coverage Aetna CVS Health requires prior authorization for Photrexa (riboflavin ophthalmic solution) corneal cross-linking in Michigan. Key requirements: progressive keratoconus documented by serial Kmax readings (≥1 diopter increase over 12 months), corneal thickness ≥400 microns, and use of FDA-approved iLink system. Submit via Aetna&

How to Get Voxzogo (Vosoritide) Covered by Aetna CVS Health in Michigan: Complete 2025 Guide with Forms and Appeals

Quick Answer: Getting Voxzogo Covered by Aetna CVS Health in Michigan Aetna CVS Health covers Voxzogo (vosoritide) for pediatric achondroplasia patients with open growth plates. Your fastest path to approval: (1) Confirm your child has documented achondroplasia via genetic testing or clinical/X-ray findings, (2) Verify open epiphyses through imaging,